1. Home
  2. PFGC vs ITCI Comparison

PFGC vs ITCI Comparison

Compare PFGC & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFGC
  • ITCI
  • Stock Information
  • Founded
  • PFGC 1885
  • ITCI 2002
  • Country
  • PFGC United States
  • ITCI United States
  • Employees
  • PFGC N/A
  • ITCI N/A
  • Industry
  • PFGC Food Distributors
  • ITCI Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFGC Consumer Discretionary
  • ITCI Health Care
  • Exchange
  • PFGC Nasdaq
  • ITCI Nasdaq
  • Market Cap
  • PFGC 13.2B
  • ITCI 13.5B
  • IPO Year
  • PFGC 2015
  • ITCI N/A
  • Fundamental
  • Price
  • PFGC $81.86
  • ITCI $128.60
  • Analyst Decision
  • PFGC Strong Buy
  • ITCI Buy
  • Analyst Count
  • PFGC 9
  • ITCI 13
  • Target Price
  • PFGC $95.89
  • ITCI $103.92
  • AVG Volume (30 Days)
  • PFGC 1.4M
  • ITCI 2.2M
  • Earning Date
  • PFGC 02-05-2025
  • ITCI 02-21-2025
  • Dividend Yield
  • PFGC N/A
  • ITCI N/A
  • EPS Growth
  • PFGC N/A
  • ITCI N/A
  • EPS
  • PFGC 2.48
  • ITCI N/A
  • Revenue
  • PFGC $56,500,600,000.00
  • ITCI $613,728,000.00
  • Revenue This Year
  • PFGC $17.34
  • ITCI $48.28
  • Revenue Next Year
  • PFGC $5.25
  • ITCI $37.34
  • P/E Ratio
  • PFGC $34.09
  • ITCI N/A
  • Revenue Growth
  • PFGC 4.69
  • ITCI 46.08
  • 52 Week Low
  • PFGC $61.60
  • ITCI $63.30
  • 52 Week High
  • PFGC $92.44
  • ITCI $128.77
  • Technical
  • Relative Strength Index (RSI)
  • PFGC 34.25
  • ITCI 83.90
  • Support Level
  • PFGC $83.10
  • ITCI $126.88
  • Resistance Level
  • PFGC $88.46
  • ITCI $128.19
  • Average True Range (ATR)
  • PFGC 2.59
  • ITCI 0.41
  • MACD
  • PFGC -0.56
  • ITCI -1.30
  • Stochastic Oscillator
  • PFGC 2.52
  • ITCI 91.01

About PFGC Performance Food Group Company

Performance Food Group Co is the third-largest U.S. food-service distributor behind Sysco and us Foods, with 9% market share. PFG's food-service business (52% of 2022 sales) provides customized food products and services (such as product selection and procurement) to independent and chain restaurants, and institutional customers. Acquisitions of Eby-Brown (2019) and Core-Mark (2021) enabled PFG to tap into the convenience store segment (41% of sales), offering convenience products, marketing programs, and technology solutions to convenience stores, drug stores, and other such channels. The firm's Vistar business (7% of sales) is a national distributor of candy, snacks, and beverages to vending and office coffee service distributors, theaters, and hospitality providers.

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Share on Social Networks: